Textainer Group Holdings Limited (TGH) Reaches $24.75 52-Week High; Brown Capital Management Has Lowered Abiomed (ABMD) Holding By $1.24 Million

January 14, 2018 - By wolcottdaily

Brown Capital Management Llc decreased Abiomed Inc (ABMD) stake by 0.53% reported in 2017Q3 SEC filing. Brown Capital Management Llc sold 7,406 shares as Abiomed Inc (ABMD)’s stock rose 15.32%. The Brown Capital Management Llc holds 1.39 million shares with $233.86M value, down from 1.39M last quarter. Abiomed Inc now has $9.51B valuation. The stock increased 2.36% or $4.96 during the last trading session, reaching $215.11. About 283,376 shares traded. ABIOMED, Inc. (NASDAQ:ABMD) has risen 40.97% since January 14, 2017 and is uptrending. It has outperformed by 24.27% the S&P500.

The stock of Textainer Group Holdings Limited (NYSE:TGH) hit a new 52-week high and has $25.49 target or 3.00% above today’s $24.75 share price. The 5 months bullish chart indicates low risk for the $1.41 billion company. The 1-year high was reported on Jan, 14 by Barchart.com. If the $25.49 price target is reached, the company will be worth $42.21M more. The stock increased 3.77% or $0.9 during the last trading session, reaching $24.75. About 230,776 shares traded. Textainer Group Holdings Limited (NYSE:TGH) has declined 15.78% since January 14, 2017 and is downtrending. It has underperformed by 32.48% the S&P500.

Among 12 analysts covering Abiomed (NASDAQ:ABMD), 10 have Buy rating, 0 Sell and 2 Hold. Therefore 83% are positive. Abiomed had 26 analyst reports since August 4, 2015 according to SRatingsIntel. The stock of ABIOMED, Inc. (NASDAQ:ABMD) earned “Buy” rating by Jefferies on Thursday, November 2. On Tuesday, August 9 the stock rating was maintained by Jefferies with “Buy”. As per Wednesday, August 5, the company rating was maintained by Northland Capital. Piper Jaffray maintained it with “Buy” rating and $220.0 target in Thursday, January 4 report. The company was maintained on Thursday, December 21 by Jefferies. The firm earned “Buy” rating on Thursday, September 21 by Jefferies. The firm earned “Buy” rating on Thursday, June 29 by Jefferies. The firm earned “Buy” rating on Tuesday, August 4 by Benchmark. The stock of ABIOMED, Inc. (NASDAQ:ABMD) earned “Overweight” rating by PiperJaffray on Thursday, April 6. The firm has “Buy” rating given on Tuesday, June 6 by Jefferies.

Investors sentiment decreased to 1.3 in Q3 2017. Its down 0.13, from 1.43 in 2017Q2. It dropped, as 27 investors sold ABMD shares while 89 reduced holdings. 55 funds opened positions while 96 raised stakes. 38.51 million shares or 1.21% less from 38.99 million shares in 2017Q2 were reported. 3,668 are held by Proshare Advsrs Ltd Liability Corp. State Street Corp has 1.10 million shares for 0.02% of their portfolio. Employees Retirement Sys Of Texas accumulated 0.03% or 12,000 shares. Natixis Asset owns 656 shares. First Manhattan Co owns 7,994 shares or 0.01% of their US portfolio. Guggenheim Cap Ltd Llc reported 0.07% of its portfolio in ABIOMED, Inc. (NASDAQ:ABMD). Capital One National Association invested 0.03% in ABIOMED, Inc. (NASDAQ:ABMD). Northwestern Mutual Wealth Mgmt invested in 9,994 shares. Deutsche Bancorporation Ag has invested 0.01% in ABIOMED, Inc. (NASDAQ:ABMD). Tiaa Cref Invest Ltd Llc stated it has 190,639 shares. 21,894 were accumulated by Allen Investment Mngmt Ltd Com. 80,440 were accumulated by Thrivent For Lutherans. California-based Lpl Limited Liability Co has invested 0.01% in ABIOMED, Inc. (NASDAQ:ABMD). Texan Capital Mngmt holds 1.27% or 11,385 shares in its portfolio. 1832 Asset L P, Ontario – Canada-based fund reported 353,800 shares.

Analysts await ABIOMED, Inc. (NASDAQ:ABMD) to report earnings on January, 25. They expect $0.50 EPS, up 47.06% or $0.16 from last year’s $0.34 per share. ABMD’s profit will be $22.11 million for 107.56 P/E if the $0.50 EPS becomes a reality. After $0.44 actual EPS reported by ABIOMED, Inc. for the previous quarter, Wall Street now forecasts 13.64% EPS growth.

Since July 31, 2017, it had 0 insider purchases, and 5 selling transactions for $9.51 million activity. $2.44 million worth of stock was sold by Weber David M on Monday, July 31. 982 shares were sold by ROSE ERIC A MD, worth $142,554. $1.91 million worth of ABIOMED, Inc. (NASDAQ:ABMD) was sold by Greenfield Andrew J. THOMAS PAUL also sold $1.55M worth of ABIOMED, Inc. (NASDAQ:ABMD) on Tuesday, August 15.

Textainer Group Holdings Limited, through its subsidiaries, engages in the purchase, ownership, management, leasing, and disposal of a fleet of intermodal containers worldwide. The company has market cap of $1.41 billion. It operates through three divisions: Container Ownership, Container Management, and Container Resale. It has a 363.97 P/E ratio. The firm owns and leases standard dry freight and special-purpose containers, as well as refrigerated containers.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.